Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Medtronic Goes Trolling? Kyphon Patents Are Basis Of New Suits, But Not From Medtronic

This article was originally published in The Gray Sheet

Executive Summary

Recently incorporated Orthophoenix, which shares the same Dallas address as IPNav, a company that provides “full-service patent monetization,” is suing six device firms for infringement of the Medtronic kyphoplasty patents it recently acquired.

You may also be interested in...



Patent Troll Legislation Gets Attention At Senate Hearing

Biotechnology Industry Organization throws support behind Senate bill’s revisions to the inter partes review process, argues against provisions in House measure.

Medtronic Announces New Kyphoplasty Platform

The firm says the new system will give physicians more options to treat patients with a varying severity of spinal injury.

Medical Device Patents Surging, Industry Players Forecast The Future

With recent changes to US patent laws, a landmark US Supreme Court decision, and the emergence of so-called “patent trolls” in the medical device community, it seems everyone is talking patents. Medical device patents and litigation are “booming,” according to industry experts, and medtech companies need to pay close attention.

Related Content

Topics

Related Companies

Latest News
See All
UsernamePublicRestriction

Register

MT032151

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel